Skip to content Skip to footer

U.S. Indices Close In On Record Highs

The Dow Jones set a new high to start the trading week, as markets geared up for a big few days of meetings from key Central Banks.

The main being the FOMC meeting this Wednesday, which has seen traders already taking their positions prior to the event.

Many believe that inflation will be a huge discussion point this week, as such former Fed chair, and now Treasury Secretary Janet Yellen, gave her views on the matter.

In an interview she stated, “Currently the risk of inflation is small and manageable. I don’t think it’s a significant risk, and if it materializes, we’ll certainly monitor for it, but we have tools to address it.”

The benchmark S&P 500 also rose on Monday, closing in on its own record high of 3963.

Bitcoin rallies to new high over $60,000

Another weekend has passed, and yet again another key milestone has been reached in the world of Cryptocurrency.

This time, Bitcoin broke above the $60,000 level as it set yet another record high, this time trading at a high of $61,742.

The move came despite the news that India will propose a law banning cryptocurrencies, and subsequently fining anyone who trades or even holds these digital assets.

As with recent ATH’s in BTCUSD, prices have since dropped back, with many likely closing their trades.

BTCUSD is currently trading at $56,627.

Related: An Agitaded Week For Bitcoin

AstraZeneca vaccine suspended in Europe

Several countries in Europe have made the decision to suspend the circulation of AstraZeneca’s COVID-19 vaccine, amid concerns of blood clots.

After firstly being suspended by Ireland, Germany, France, Italy and the Netherlands moved to take similar action.

The concern raised is that the jab in some cases may cause blood clotting issues, however many have stated that the suspension is only one of precaution.

Irish PM Micheal Martin stated, “There is no causal effect established or anything like that yet, but as a precautionary move in line with the precautionary principle, our clinical advice was to pause the program whilst the EMA does a review of this”.

Both the European Medicines Agency and AstraZeneca have so far pushed back on concerns.

Quote of the day – “Every trader has strengths and weaknesses. Some are good holders of winners but may hold their losers a little too long. Others may cut their winners a little short but are quick to take their losses. As long as you stick to your own style, you get the good and bad in your own approach.”

– Michael Marcus

Tradeview Ltd. is not a portfolio manager or an investment advisor. This Market Report is for informational purposes only. Any statements made or opinions voiced in this Market Report do not constitute investment advice. The Tradeview Ltd. Market Report does not constitute a solicitation to buy or sell in the financial markets. Although the information contained in the Market Report comes from trusted sources, Tradeview Ltd. is not responsible for guaranteeing the accuracy, timeliness, completeness, or fitness of such sources. Tradeview Ltd. shall not be responsible for and disclaims all liability for any losses which may be suffered from access and use of the contents of the Tradeview Ltd. Market Report. Trading any financial instrument on margin, using leverage or otherwise involves considerable risk. Therefore, before deciding to participate in any style of trading, you should carefully consider your investment objectives, level of experience and risk appetite. Most importantly, do not invest money you cannot afford to lose. Consulting with your investment counselor, attorney, accountant or other professional upon whom you rely for guidance as to the appropriateness of an investment in any style of trading is recommended.

Tradeview Ltd.

Is licensed to carry on securities investment business and is regulated by the Cayman Islands Monetary Authority (CIMA) as a full securities broker-dealer. Tradeview conducts business pursuant to the Cayman Islands Securities Investment Business Law (SIBL) and its activities fall under the direct supervision of the Investments and Securities Division of CIMA.
Headquarters: 5th Floor Anderson Square, 64 Shedden Road, Georgetown, Grand Cayman, Cayman Islands KY1-1002, BWI.
Website: www.tradeviewforex.com

Tradeview Asia Ltd.

Is licensed and regulated by the Labuan Financial Services Authority (FSA) as a Money Broker, registration number LL15870 licensed to facilitate transactions in foreign exchange pursuant to Labuan Financial Services and Securities Act 2010, the Labuan Companies Act 1990 and the Labuan Business Activity Tax Act 1990.
Headquarters: International Business Financial Centre at Office 5, Jamie Business Center I, Unit F10, First Floor, Paragon Labuan, Jalan Mustapha, 87000 Labuan F.T.
Website: www.tvmgloballtd.com

Tradeview Europe Ltd.

Is licensed as a Category 2 Investment Service Company and is regulated by the Malta Financial Services Authority (MFSA). The Malta Financial Services Authority (MFSA) is the single regulator for financial services in Malta. MFSA is a fully autonomous public institution and reports to Parliament on an annual basis. The MFSA is a member of the European Banking Authority (EBA), the European Securities and Markets Authority (ESMA) and the International Organization of Securities Commissions (IOSCO) and is a signatory of the Multilateral Memorandum of Understanding with other European regulatory Institutions. Tradeview is authorized to provide financial services across multiple asset classes and is passported in the EU/EEA under MiFID II (EU Markets in Financial Instruments Directive).
Headquarters: 157 Archbishops Street, Valletta VLT Malta 1440.
Website: www.tradeview.eu

Tradeview Financial Markets S.A.C Global

Is authorized to conduct business pursuant to and in compliance with the General Law of Companies (LGS) promulgated by the government of Peru. Tradeview Financial Markets S.A.C is registered with the National Superintendence of Public Registries (SUNARP), company number 13089531. Tradeview Financial Markets S.A.C provides financial services in selected OTC derivative markets in compliance with all applicable government regulations.
Headquarters: Los Mirtos 239 Urb. San Eugenio, Lince, Lima, Perú.
Website: www.tradeviewlatam.com